Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-16-088355

Director sold 22,086 shares at $11.18 ($247,008)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SHANNON TIMOTHY M Director 2016-11-29 Sale −22,086 $11.18 $247,008 3,244,381 I: show line 1 in the form
Open-market sales · 22,086 sh · avg $11.18 · $247,008
Loading xslF345X03/doc1.xml…